Today on MedNet21, we're going to discuss Multiple Sclerosis.
This presentation provides an overview of the epidemiological, clinical and pathological characteristics of Multiple Sclerosis (MS). The current use of disease modifying therapies to suppress MS relapses and new lesion formation, and the mechanisms of action of some of the most recently approved agents, will be discussed. Recent data about the impact of COVID19 on people with MS will be reviewed.
Dates and Times
End Date: 10/16/2023
ObjectivesAs a result of this educational activity, webcast participants will be able to: LEARN about the typical
clinical course of multiple sclerosis and disease modifying treatments; and LEARN about our current understanding of the pathogenesis of MS.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.